"The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at ...

In an editorial article published in the New England Journal of Medicine, Dr. Vinay Prasad, the newly appointed head of the ...

The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and ...

Here, we take a look at who’s in at the FDA, who’s out, and what could be next for the agency’s leadership ... navigating the future of the FDA’s vaccine division at a time when HHS ...

Prasad's appointment marks the latest addition of a medical skeptic and critics of COVID-19 policies to federal health leadership.

The Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center for Biologics Evaluation and ...

The FDA's decision to appoint Vinay Prasad, MD, MPH, to head its Center for Biologics Evaluation and Research (CBER) raised ...

US FDA Names Agency Critic Vinay Prasad as Top Vaccine Official By Dan Levine ... an oncologist who has previously criticized FDA leadership and COVID-19 mandates, as the director of its Center ...

(Reuters) -The U.S. Food and Drug Administration has named Vinay Prasad, an oncologist who has previously criticized FDA leadership ... COVID-19 vaccines and was pushed out of the agency in ...